TY - STD TI - Maude SL, Laetsch TW, Buechner J, et al. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia. N Engl J Med. 2018;378(5):439–48. ID - ref1 ER - TY - JOUR AU - June, C. H. AU - Sadelain, M. PY - 2018 DA - 2018// TI - Chimeric antigen receptor therapy JO - N Engl J Med VL - 379 UR - https://doi.org/10.1056/NEJMra1706169 DO - 10.1056/NEJMra1706169 ID - June2018 ER - TY - JOUR AU - Davila, M. L. AU - Riviere, I. AU - Wang, X. PY - 2014 DA - 2014// TI - Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia JO - Sci Transl Med VL - 6 UR - https://doi.org/10.1126/scitranslmed.3008226 DO - 10.1126/scitranslmed.3008226 ID - Davila2014 ER - TY - JOUR AU - Lee, D. W. AU - Kochenderfer, J. N. AU - Stetler-Stevenson, M. PY - 2015 DA - 2015// TI - T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial JO - Lancet VL - 385 UR - https://doi.org/10.1016/S0140-6736(14)61403-3 DO - 10.1016/S0140-6736(14)61403-3 ID - Lee2015 ER - TY - JOUR AU - Maude, S. L. AU - Frey, N. AU - Shaw, P. A. PY - 2014 DA - 2014// TI - Chimeric antigen receptor T cells for sustained remissions in leukemia JO - N Engl J Med VL - 371 UR - https://doi.org/10.1056/NEJMoa1407222 DO - 10.1056/NEJMoa1407222 ID - Maude2014 ER - TY - STD TI - Dai H, Wang Y, Lu X, Han W. Chimeric antigen receptors modified T-cells for cancer therapy. J Natl Cancer Inst. 2016;108(7). ID - ref6 ER - TY - JOUR AU - Dai, H. AU - Zhang, W. AU - Li, X. PY - 2015 DA - 2015// TI - Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemia JO - Oncoimmunology VL - 4 UR - https://doi.org/10.1080/2162402X.2015.1027469 DO - 10.1080/2162402X.2015.1027469 ID - Dai2015 ER - TY - JOUR AU - Sotillo, E. AU - Barrett, D. M. AU - Black, K. L. PY - 2015 DA - 2015// TI - Convergence of acquired mutations and alternative splicing of CD19 enables resistance to CART-19 immunotherapy JO - Cancer Discov VL - 5 UR - https://doi.org/10.1158/2159-8290.CD-15-1020 DO - 10.1158/2159-8290.CD-15-1020 ID - Sotillo2015 ER - TY - JOUR AU - Orlando, E. J. AU - Han, X. AU - Tribouley, C. PY - 2018 DA - 2018// TI - Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia JO - Nat Med VL - 24 UR - https://doi.org/10.1038/s41591-018-0146-z DO - 10.1038/s41591-018-0146-z ID - Orlando2018 ER - TY - JOUR AU - Evans, A. G. AU - Rothberg, P. G. AU - Burack, W. R. PY - 2015 DA - 2015// TI - Evolution to plasmablastic lymphoma evades CD19-directed chimeric antigen receptor T cells JO - Br J Haematol VL - 171 UR - https://doi.org/10.1111/bjh.13562 DO - 10.1111/bjh.13562 ID - Evans2015 ER - TY - JOUR AU - Fry, T. J. AU - Shah, N. N. AU - Orentas, R. J. PY - 2018 DA - 2018// TI - CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy JO - Nat Med VL - 24 UR - https://doi.org/10.1038/nm.4441 DO - 10.1038/nm.4441 ID - Fry2018 ER - TY - JOUR AU - Grada, Z. AU - Hegde, M. AU - Byrd, T. PY - 2013 DA - 2013// TI - TanCAR: a novel bispecific chimeric antigen receptor for cancer immunotherapy JO - Mol Ther Nucleic Acids VL - 2 UR - https://doi.org/10.1038/mtna.2013.32 DO - 10.1038/mtna.2013.32 ID - Grada2013 ER - TY - JOUR AU - Hegde, M. AU - Corder, A. AU - Chow, K. K. PY - 2013 DA - 2013// TI - Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma JO - Mol Ther VL - 21 UR - https://doi.org/10.1038/mt.2013.185 DO - 10.1038/mt.2013.185 ID - Hegde2013 ER - TY - JOUR AU - Bielamowicz, K. AU - Fousek, K. AU - Byrd, T. T. PY - 2018 DA - 2018// TI - Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma JO - Neuro Oncol VL - 20 UR - https://doi.org/10.1093/neuonc/nox182 DO - 10.1093/neuonc/nox182 ID - Bielamowicz2018 ER - TY - JOUR AU - Hegde, M. AU - Mukherjee, M. AU - Grada, Z. PY - 2016 DA - 2016// TI - Tandem CAR T cells targeting HER2 and IL13Ralpha2 mitigate tumor antigen escape JO - J Clin Invest VL - 126 UR - https://doi.org/10.1172/JCI83416 DO - 10.1172/JCI83416 ID - Hegde2016 ER - TY - JOUR AU - Gattinoni, L. AU - Finkelstein, S. E. AU - Klebanoff, C. A. PY - 2005 DA - 2005// TI - Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells JO - J Exp Med VL - 202 UR - https://doi.org/10.1084/jem.20050732 DO - 10.1084/jem.20050732 ID - Gattinoni2005 ER - TY - JOUR AU - Talmadge, J. E. AU - Gabrilovich, D. I. PY - 2013 DA - 2013// TI - History of myeloid-derived suppressor cells JO - Nat Rev Cancer VL - 13 UR - https://doi.org/10.1038/nrc3581 DO - 10.1038/nrc3581 ID - Talmadge2013 ER - TY - JOUR AU - Turtle, C. J. AU - Hanafi, L. A. AU - Berger, C. PY - 2016 DA - 2016// TI - CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients JO - J Clin Invest VL - 126 UR - https://doi.org/10.1172/JCI85309 DO - 10.1172/JCI85309 ID - Turtle2016 ER - TY - STD TI - van Dongen JJ, van der Velden VH, Bruggemann M, Orfao A. Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies. Blood. 2015;125(26):3996–4009. ID - ref19 ER - TY - STD TI - Park JH, Riviere I, Gonen M, et al. Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia. N Engl J Med. 2018;378(5):449–59. ID - ref20 ER - TY - JOUR AU - Fielding, A. K. AU - Richards, S. M. AU - Chopra, R. PY - 2007 DA - 2007// TI - Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study JO - Blood VL - 109 UR - https://doi.org/10.1182/blood-2006-05-018192 DO - 10.1182/blood-2006-05-018192 ID - Fielding2007 ER - TY - JOUR AU - Gokbuget, N. AU - Stanze, D. AU - Beck, J. PY - 2012 DA - 2012// TI - Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation JO - Blood VL - 120 UR - https://doi.org/10.1182/blood-2011-12-399287 DO - 10.1182/blood-2011-12-399287 ID - Gokbuget2012 ER - TY - JOUR AU - Kalos, M. AU - Levine, B. L. AU - Porter, D. L. PY - 2011 DA - 2011// TI - T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia JO - Sci Transl Med VL - 3 UR - https://doi.org/10.1126/scitranslmed.3002842 DO - 10.1126/scitranslmed.3002842 ID - Kalos2011 ER - TY - JOUR AU - Kochenderfer, J. N. AU - Dudley, M. E. AU - Kassim, S. H. PY - 2015 DA - 2015// TI - Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2014.56.2025 DO - 10.1200/JCO.2014.56.2025 ID - Kochenderfer2015 ER - TY - JOUR AU - Lee, D. W. AU - Gardner, R. AU - Porter, D. L. PY - 2014 DA - 2014// TI - Current concepts in the diagnosis and management of cytokine release syndrome JO - Blood VL - 124 UR - https://doi.org/10.1182/blood-2014-05-552729 DO - 10.1182/blood-2014-05-552729 ID - Lee2014 ER - TY - JOUR AU - Lee, D. W. AU - Santomasso, B. D. AU - Locke, F. L. PY - 2019 DA - 2019// TI - ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells JO - Biol Blood Marrow Transplant VL - 25 UR - https://doi.org/10.1016/j.bbmt.2018.12.758 DO - 10.1016/j.bbmt.2018.12.758 ID - Lee2019 ER - TY - JOUR AU - Forman, S. J. AU - Rowe, J. M. PY - 2013 DA - 2013// TI - The myth of the second remission of acute leukemia in the adult JO - Blood VL - 121 UR - https://doi.org/10.1182/blood-2012-08-234492 DO - 10.1182/blood-2012-08-234492 ID - Forman2013 ER - TY - JOUR AU - Majzner, R. G. AU - Mackall, C. L. PY - 2018 DA - 2018// TI - Tumor antigen escape from CAR T-cell therapy JO - Cancer Discov VL - 8 UR - https://doi.org/10.1158/2159-8290.CD-18-0442 DO - 10.1158/2159-8290.CD-18-0442 ID - Majzner2018 ER - TY - JOUR AU - Qin, H. AU - Ramakrishna, S. AU - Nguyen, S. PY - 2018 DA - 2018// TI - Preclinical development of bivalent chimeric antigen receptors targeting both CD19 and CD22 JO - Mol Ther Oncolytics VL - 11 UR - https://doi.org/10.1016/j.omto.2018.10.006 DO - 10.1016/j.omto.2018.10.006 ID - Qin2018 ER - TY - JOUR AU - Zah, E. AU - Lin, M. Y. AU - Silva-Benedict, A. AU - Jensen, M. C. AU - Chen, Y. Y. PY - 2016 DA - 2016// TI - T cells expressing CD19/CD20 bispecific chimeric antigen receptors prevent antigen escape by malignant B cells JO - Cancer Immunol Res VL - 4 UR - https://doi.org/10.1158/2326-6066.CIR-15-0231 DO - 10.1158/2326-6066.CIR-15-0231 ID - Zah2016 ER - TY - JOUR AU - Turtle, C. J. AU - Hanafi, L. A. AU - Berger, C. PY - 2016 DA - 2016// TI - Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cells JO - Sci Transl Med VL - 8 UR - https://doi.org/10.1126/scitranslmed.aaf8621 DO - 10.1126/scitranslmed.aaf8621 ID - Turtle2016 ER - TY - JOUR AU - Haneen Shalabi, N. N. S. AU - Fry, T. J. AU - Yates, B. AU - Delbrook, C. AU - Yuan, C. AU - Stetler-Stevenson, M. AU - Ramakrishna, S. PY - 2017 DA - 2017// TI - Intensification of lymphodepletion optimizes CAR re-treatment efficacy JO - Blood VL - 130 ID - Haneen Shalabi2017 ER - TY - JOUR AU - Maus, M. V. AU - Haas, A. R. AU - Beatty, G. L. PY - 2013 DA - 2013// TI - T cells expressing chimeric antigen receptors can cause anaphylaxis in humans JO - Cancer Immunol Res VL - 1 UR - https://doi.org/10.1158/2326-6066.CIR-13-0006 DO - 10.1158/2326-6066.CIR-13-0006 ID - Maus2013 ER - TY - JOUR AU - Hamieh, M. AU - Dobrin, A. AU - Cabriolu, A. PY - 2019 DA - 2019// TI - CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape JO - Nature VL - 568 UR - https://doi.org/10.1038/s41586-019-1054-1 DO - 10.1038/s41586-019-1054-1 ID - Hamieh2019 ER - TY - JOUR AU - Shalabi, H. AU - Kraft, I. L. AU - Wang, H. W. PY - 2018 DA - 2018// TI - Sequential loss of tumor surface antigens following chimeric antigen receptor T-cell therapies in diffuse large B-cell lymphoma JO - Haematologica VL - 103 UR - https://doi.org/10.3324/haematol.2017.183459 DO - 10.3324/haematol.2017.183459 ID - Shalabi2018 ER - TY - JOUR AU - Wang, N. AU - Hu, X. AU - Cao, W. PY - 2020 DA - 2020// TI - Efficacy and safety of CAR19/22 T-cell cocktail therapy in patients with refractory/relapsed B-cell malignancies JO - Blood VL - 135 UR - https://doi.org/10.1182/blood.2019000017 DO - 10.1182/blood.2019000017 ID - Wang2020 ER - TY - JOUR AU - Pan, J. AU - Yang, J. F. AU - Deng, B. P. PY - 2017 DA - 2017// TI - High efficacy and safety of low-dose CD19-directed CAR-T cell therapy in 51 refractory or relapsed B acute lymphoblastic leukemia patients JO - Leukemia VL - 31 UR - https://doi.org/10.1038/leu.2017.145 DO - 10.1038/leu.2017.145 ID - Pan2017 ER - TY - JOUR AU - Teachey, D. T. AU - Rheingold, S. R. AU - Maude, S. L. PY - 2013 DA - 2013// TI - Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy JO - Blood VL - 121 UR - https://doi.org/10.1182/blood-2013-02-485623 DO - 10.1182/blood-2013-02-485623 ID - Teachey2013 ER - TY - JOUR AU - Risma, K. AU - Jordan, M. B. PY - 2012 DA - 2012// TI - Hemophagocytic lymphohistiocytosis: updates and evolving concepts JO - Curr Opin Pediatr VL - 24 UR - https://doi.org/10.1097/MOP.0b013e32834ec9c1 DO - 10.1097/MOP.0b013e32834ec9c1 ID - Risma2012 ER - TY - JOUR AU - Giavridis, T. AU - Stegen, S. J. C. AU - Eyquem, J. AU - Hamieh, M. AU - Piersigilli, A. AU - Sadelain, M. PY - 2018 DA - 2018// TI - CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade JO - Nat Med VL - 24 UR - https://doi.org/10.1038/s41591-018-0041-7 DO - 10.1038/s41591-018-0041-7 ID - Giavridis2018 ER - TY - JOUR AU - Norelli, M. AU - Camisa, B. AU - Barbiera, G. PY - 2018 DA - 2018// TI - Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells JO - Nat Med VL - 24 UR - https://doi.org/10.1038/s41591-018-0036-4 DO - 10.1038/s41591-018-0036-4 ID - Norelli2018 ER - TY - JOUR AU - Teachey, D. T. AU - Lacey, S. F. AU - Shaw, P. A. PY - 2016 DA - 2016// TI - Identification of predictive biomarkers for cytokine release syndrome after chimeric antigen receptor T-cell Therapy for acute lymphoblastic leukemia JO - Cancer Discov VL - 6 UR - https://doi.org/10.1158/2159-8290.CD-16-0040 DO - 10.1158/2159-8290.CD-16-0040 ID - Teachey2016 ER - TY - STD TI - Brudno JN, Kochenderfer JN. Toxicities of chimeric antigen receptor T cells: recognition and management. Blood. 2016;127(26):3321–30. ID - ref43 ER -